GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Net Investment Income

Fennec Pharmaceuticals (TSX:FRX) Net Investment Income


View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Net Investment Income?

Net Investment Income only applies to insurance companies.


Fennec Pharmaceuticals Business Description

Traded in Other Exchanges
Address
68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Executives
Chris Anigeron Rallis Director
Rostislav Christov Raykov Director, Senior Officer
Robert Christopher Andrade Senior Officer
Adrian J. Haigh Senior Officer
Khalid Islam Director